Key Scientific Attributes High-purity 5-Amino-1MQ ( 99% by HPLC/MS) Verified structure: 5-amino-1-methylquinolinium Crystalline powder for long-term stability Full Certificate of Analysis (COA) with HPLC, MS, NMR, and NNMT inhibition assay (IC confirmation) Manufactured in GMP-aligned, ISO-compliant facilities Suitable for NNMT inhibition, NAD+ modulation, and metabolic pathway studies in laboratory settings Research-Referenced Attributes (Based on scientific literature
aemia, certain gut surgeries, or dietary restrictions
Megaloblastic anemia caused by vitamin B12 deficiency
Delayed Treatment: Vitamin B12 deficiency left untreated for longer than 3 months may cause permanent spinal cord and nerve damage
The standard AOD 9604 dosage in clinical use is 250500 mcg, administered subcutaneously once every morning on an empty stomach, and cycled in 412-week blocks